Race Day Fundraising Success for Newcastle Cystic Fibrosis Community

Race Day Fundraising Success for Newcastle Cystic Fibrosis Community

Newcastle Cystic Fibrosis supporters filled the Trackside Marquee with red roses on Saturday 10th June with the Newcastle Cystic Fibrosis Race Day, supported by major sponsor Peabody.

The Trackside Marquee at full capacity, nearly 400 guests enjoyed racing, entertainment, and fundraising. Generous prize donations from Race Day sponsors and local businesses aided the fundraising activities which included raffles, auctions, red roses and mystery bag lucky dips. Raising over $60,000 and still counting donations flowing in for much needed support of our regions Cystic Fibrosis (CF) patients and their families.

Newcastle Racecourse CEO Duane Dowell was delighted to hear that the CF Race Day was such a great success.

“We get great satisfaction from assisting charity groups like CF to raise much needed funds to support local people and this is something we will continue to expand on.”

The Newcastle Racecourse and Newcastle Cystic Fibrosis’ relationship stems back to 2002- Sisters Jodi & Carolyn Boyd Started the Race Day in memory of daughter Katie Boyd. Katie’s father Stuart was a former Jockey at the club. Linda Cheese, CNC of the John Hunter Children’s Hospital Respiratory and Cystic Fibrosis service took over the event in 2009 and has been coordinator for the past 14 years. “From all reports it was a fantastic day and proving to be a very successful fundraiser. All our guests, sponsors, entertainers and assistants commented on it being one of the best race days they have attended, the funds raised will help both the Paediatric & Adult clinics at JHH PLUS CF Community Care & CF Australia for research.” Linda said.

Cystic fibrosis (also called CF) is a life-limiting genetic condition affecting 3,500 Australian, with no current cure. Treatment requires intensive daily physiotherapy to clear the lungs and airways, countless medications, and frequent hospitalisations. 1 in 25 people carry the recessive CF gene change, Babies born today with CF can expect to live well into adulthood.
A recent breakthrough with new a medication (Trikafta), has been life changing for many CF patients, leading to profound improvement in quality of life. Sadly, this treatment is not available for all people living with CF, it is imperative research remains ongoing, so that everyone affected by CF can have the same brighter future.



– Ends –
For further details, or to arrange an interview with CEO Duane Dowell, please contact Isabella Heintze, Marketing Coordinator on 0402 942 394